Ciclosporin topical gel - Perioc

Drug Profile

Ciclosporin topical gel - Perioc

Latest Information Update: 06 Sep 2017

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Perioc
  • Class Antineoplastics; Antipsoriatics; Antirheumatics; Ciclosporins; Eye disorder therapies; Neuroprotectants
  • Mechanism of Action Cyclophilin inhibitors; Peptidylprolyl isomerase inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Phase II Periodontitis

Most Recent Events

  • 06 Sep 2017 Phase-II development is ongoing in Sweden (EudraCT2014-002625-35)
  • 01 Oct 2016 Perioc completes a phase II trial in Periodontitis (Adjunctive treatment) in Sweden (Topical)
  • 26 Jan 2015 Phase-II clinical trials in Periodontitis (Adjunctive treatment) in Sweden (Topical)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top